Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models
Titel:
Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models
Auteur:
Wicker, Christina A. Hunt, Brian G. Krishnan, Sunil Aziz, Kathryn Parajuli, Shobha Palackdharry, Sarah Elaban, William R. Wise-Draper, Trisha M. Mills, Gordon B. Waltz, Susan E. Takiar, Vinita